Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V L Herring

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|June 29, 2000
Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatographyV L Herring, J A Johnson
Journal of Chromatography|February 26, 1993
Direct high-performance liquid chromatographic determination in urine of the enantiomers of propranolol and its major basic metabolite 4-hydroxypropranololV L Herring, J A Johnson
Therapeutic Drug Monitoring|January 22, 2002
Gentamicin enzyme-linked immunosorbent assay for microdialysis samplesS D Hanes, V L Herring
Journal of Chromatography|June 14, 1991
Solid-phase extraction and direct high-performance liquid chromatographic determination of metoprolol enantiomers in plasmaV L Herring, T L Bastian, R L Lalonde
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Alternative method for determination of ceftazidime in plasma by high-performance liquid chromatographyS D Hanes, V L Herring, G C Wood
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differencesJ A Johnson, V L Herring, M S Wolfe, et al.
Pharmacotherapy|June 15, 2000
Gender differences in labetalol kinetics: importance of determining stereoisomer kinetics for racemic drugsJ A Johnson, W S Akers, V L Herring, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Effects of age on the protein binding and disposition of propranolol stereoisomersR L Lalonde, D M Tenero, B S Burlew, et al.
Clinical Pharmacology and Therapeutics|May 1, 1990
Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomersB A Hunt, M B Bottorff, V L Herring, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Labetalol pharmacokinetics and pharmacodynamics: evidence of stereoselective dispositionR L Lalonde, T L O'Rear, I W Wainer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Chromatography. B, Biomedical Sciences and Applications|June 29, 2000
Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatographyV L Herring, J A Johnson
Journal of Chromatography|February 26, 1993
Direct high-performance liquid chromatographic determination in urine of the enantiomers of propranolol and its major basic metabolite 4-hydroxypropranololV L Herring, J A Johnson
Therapeutic Drug Monitoring|January 22, 2002
Gentamicin enzyme-linked immunosorbent assay for microdialysis samplesS D Hanes, V L Herring
Journal of Chromatography|June 14, 1991
Solid-phase extraction and direct high-performance liquid chromatographic determination of metoprolol enantiomers in plasmaV L Herring, T L Bastian, R L Lalonde
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Alternative method for determination of ceftazidime in plasma by high-performance liquid chromatographyS D Hanes, V L Herring, G C Wood
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differencesJ A Johnson, V L Herring, M S Wolfe, et al.
Pharmacotherapy|June 15, 2000
Gender differences in labetalol kinetics: importance of determining stereoisomer kinetics for racemic drugsJ A Johnson, W S Akers, V L Herring, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Effects of age on the protein binding and disposition of propranolol stereoisomersR L Lalonde, D M Tenero, B S Burlew, et al.
Clinical Pharmacology and Therapeutics|May 1, 1990
Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomersB A Hunt, M B Bottorff, V L Herring, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Labetalol pharmacokinetics and pharmacodynamics: evidence of stereoselective dispositionR L Lalonde, T L O'Rear, I W Wainer, et al.
Pageof 2